Quick Takeaways
- Timothy P. Walbert has 8 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,046,599.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Timothy P. Walbert
- Location
- Park Ridge, IL
- Summary
- The estimated net worth of Timothy P. Walbert is at least $1,046,599 dollars as of 07 May 2026. Timothy P. Walbert is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $642.1K. Timothy P. Walbert is the Director of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $404.5K.
- Signature
- /s/ Jolie M. Siegel, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Timothy P. Walbert and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: BIOMARIN PHARMACEUTICAL INC ($642,143).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Timothy P. Walbert
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | Director | $642,143 | 20 May 2025 | ||
| MIRM | Mirum Pharmaceuticals, Inc. | Director | $404,456 | 29 May 2025 | ||
| AUPH | Aurinia Pharmaceuticals Inc. | Director | 18 May 2022 | |||
| IPSC | Century Therapeutics, Inc. | Director | 12 Jun 2025 | |||
| XCUR | EXICURE, INC. | Director | 02 Jun 2021 | |||
| HZNP | Horizon Therapeutics Public Ltd Co | Chairman, President and CEO, Director | 06 Oct 2023 | |||
| ODTX | Odyssey Therapeutics, Inc. | Director | 07 May 2026 | |||
| SGMT | Sagimet Biosciences Inc. | Director | 09 Jun 2025 |
Insider Transactions Reported by Timothy P. Walbert:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.